New electric probe aims to catch hidden cancer cells during prostate removal

NCT ID NCT06039085

Recruiting now Diagnosis Sponsor: Ryan J. Halter Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a custom electrical impedance probe that measures tissue properties during prostate removal surgery. The goal is to see if it can instantly detect any cancer left behind, helping surgeons remove it all in one go. Two hundred men with prostate cancer will take part, and the device's safety and accuracy will be tracked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Electrical Impedance Imaging (EII) probe
What this could lead to: If successful, this device could help surgeons remove all cancer during prostate surgery, reducing the need for follow-up treatments.
What could go wrong: This is an early feasibility study focused on measuring electrical signals, not yet proven to improve patient outcomes. The device may not reliably distinguish cancerous from healthy tissue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Dartmouth-Hitchcock Medical Center
RECRUITING

Lebanon, New Hampshire, 03756, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.